secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sana Biotechnology, Inc. (SANA)
CIK:        0001770121
Form:       8-K
Filed at:   2024-09-12T23:59:59+00:00
Accession:  0001193125-24-218049
Event type: leadership
Sentiment:  negative
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CFO Nathan Hardy resigns effective October 4, 2024
--------------------------------------------------

- Nathan Hardy notified resignation as EVP and CFO on September 6, 2024, effective October 4, 2024.
- Resignation is voluntary for personal reasons; no disagreement with company operations or policies.
- No successor has been announced; CFO duties will be assumed by interim arrangement or search process.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770121/000119312524218049/0001193125-24-218049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770121/000119312524218049/d852081d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-218049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer